Resultado de búsqueda
Hace 2 días · Beckman Coulter es ahora un distribuidor autorizado del ensayo MeMed BV, una prueba de inmunoensayo rápido que puede diferenciar entre infecciones bacterianas y virales, y MeMed Key, un analizador de inmunoensayo compacto que está autorizado para ejecutar el ensayo MeMed BV en Estados Unidos y Europa.
9 de may. de 2024 · Using Anti-Müllerian Hormone to Determine Ovarian Reserve. BY Dr. Lindsay Sun, M.D., M.S. | May 9 2024. Globally, infertility impacts millions of couples. For women, one challenge can be a lack of ovulation. Learn how AMH testing is used to determine egg reserve and help couples achieve their dream of parenthood. Immunoassay Womens Health High ...
Hace 1 día · BREA, Calif., May 29, 2024 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, today announced U.S. Food and Drug Administration clearance of its Access NT-proBNP (N-terminal ...
Hace 1 día · The US Food and Drug Administration (FDA) has approved clinical diagnostics company Beckman Coulter’s rapid heart failure assay, Access N-terminal Pro B-type Natriuretic Peptide (NT-proBNP ...
Hace 2 días · According to the Heart Failure Society of America, nearly 6.5 million Americans over the age of 20 have heart failure, accounting for approximately 8.5% of all heart disease deaths in the United States.Beckman Coulter's Access NT-proBNP assay measures concentrations of N-terminal pro B-type natriuretic peptide in serum or plasma that originates in a person's heart.
10 de may. de 2024 · Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has entered a collaborative partnership with Watchmaker Genomics, an expert in genomics tools development for high-stringency clinical and translational applications.
Hace 1 día · Beckman Coulter, a leading name in clinical diagnostics, has recently gained approval from the U.S. Food and Drug Administration for its Access NT-proBNP (N-terminal Pro B-type Natriuretic Peptide) assay. This advancement enables the swift assessment of heart failure in under 11 minutes using the Beckman Coulter DxI 9000 Immunoassay Analyzer*.
